 |
The Journal of Neuroscience, August 10, 2005, 25(32):7406-7419; doi:10.1523/JNEUROSCI.1008-05.2005
Previous Article | Next Article 
Behavioral/Systems/Cognitive
Mechanisms of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Inhibition of Identified Green Fluorescent Protein-Expressing GABA Neurons in the Hypothalamic Neuroendocrine Arcuate Nucleus
Claudio Acuna-Goycolea,1
Nobuaki Tamamaki,2
Yuchio Yanagawa,3,4,5
Kunihiko Obata,6 and
Anthony N. van den Pol1
1Department of Neurosurgery, Yale University, New Haven, Connecticut 06520, 2Department of Morphological Neural Sciences, Kumamoto University, Kumamoto 860-8556, Japan, 3Department of Genetic and Behavioral Neuroscience, Gunma University, Maebashi 371-8511, Japan, 4Core Research for Evolutional Science and Technology and 5Solution-Oriented Research for Science and Technology, Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan, and 6Obata Research Unit, RIKEN Brain Science Institute, Wako 351-0198, Japan
The fast inhibitory transmitter GABA is robustly expressed in the arcuate nucleus (ARC) and appears to play a major role in hypothalamic regulation of endocrine function and energy homeostasis. Previously, it has not been possible to record selectively from GABA cells, because they have no defining morphological or physiological characteristics. Using transgenic mice that selectively express GFP (green fluorescent protein) in GAD67 (glutamic acid decarboxylase 67)-synthesizing cells, we identified ARC GABA neurons (n > 300) and used whole-cell recording to study their physiological response to neuropeptide Y (NPY), the related peptide YY3-36 (PYY3-36), and pancreatic polypeptide (PP), important modulators of ARC function. In contrast to other identified ARC cells in which NPY receptor agonists were reported to generate excitatory actions, we found that NPY consistently reduced the firing rate and hyperpolarized GABA neurons including neuroendocrine GABA neurons identified by antidromic median eminence stimulation. The inhibitory NPY actions were mediated by postsynaptic activation of G-protein-linked inwardly rectifying potassium (GIRK) and depression of voltage-gated calcium currents via Y1 and Y2 receptor subtypes. Additionally, NPY reduced spontaneous and evoked synaptic glutamate release onto GABA neurons by activation of Y1 and Y5 receptors. The peptide PYY3-36, a peripheral endocrine signal that can act in the brain, also inhibited GABA neurons, including identified neuroendocrine cells, by activating GIRK conductances and depressing calcium currents. The endogenous Y4 agonist PP depressed the activity of GABA-expressing neurons mainly by presynaptic attenuation of glutamate release. Together, these results show that the family of neuropeptide Y modulators reduces the activity of inhibitory GABA neurons in the ARC by multiple presynaptic and postsynaptic mechanisms.
Key words: neuroendocrine; glutamate; GABA; mediobasal hypothalamus; feeding; neuropeptide Y
Received March 15, 2005;
revised June 3, 2005;
accepted June 23, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
C. A. Perry, M. Pravetoni, J. A. Teske, C. Aguado, D. J. Erickson, J. F. Medrano, R. Lujan, C. M. Kotz, and K. Wickman
Predisposition to late-onset obesity in GIRK4 knockout mice
PNAS,
June 10, 2008;
105(23):
8148 - 8153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-Y. Fu and A. N. van den Pol
Agouti-Related Peptide and MC3/4 Receptor Agonists Both Inhibit Excitatory Hypothalamic Ventromedial Nucleus Neurons
J. Neurosci.,
May 21, 2008;
28(21):
5433 - 5449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Huang, C. Acuna-Goycolea, Y. Li, H. M. Cheng, K. Obrietan, and A. N. van den Pol
Cannabinoids Excite Hypothalamic Melanin-Concentrating Hormone But Inhibit Hypocretin/Orexin Neurons: Implications for Cannabinoid Actions on Food Intake and Cognitive Arousal
J. Neurosci.,
May 2, 2007;
27(18):
4870 - 4881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Gantz, N. Erondu, M. Mallick, B. Musser, R. Krishna, W. K. Tanaka, K. Snyder, C. Stevens, M. A. Stroh, H. Zhu, et al.
Efficacy and Safety of Intranasal Peptide YY3-36 for Weight Reduction in Obese Adults
J. Clin. Endocrinol. Metab.,
May 1, 2007;
92(5):
1754 - 1757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-Y. Fu and A. N. van den Pol
GABA excitation in mouse hilar neuropeptide Y neurons
J. Physiol.,
March 1, 2007;
579(2):
445 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Baccam, G. Alonso, T. Costecalde, P. Fontanaud, F. Molino, I. C. A. F. Robinson, P. Mollard, and P.-F. Mery
Dual-Level Afferent Control of Growth Hormone-Releasing Hormone (GHRH) Neurons in GHRH-Green Fluorescent Protein Transgenic Mice
J. Neurosci.,
February 14, 2007;
27(7):
1631 - 1641.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Acuna-Goycolea and A. N. van den Pol
Peptide YY3-36 Inhibits Both Anorexigenic Proopiomelanocortin and Orexigenic Neuropeptide Y Neurons: Implications for Hypothalamic Regulation of Energy Homeostasis
J. Neurosci.,
November 9, 2005;
25(45):
10510 - 10519.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|